List of office bearers for the period from

01.04.2023 to 31.03.2025

Mr. R.C. Juneja - CEO & Chairman, Mankind Pharma Ltd.
Mr. Juneja, the founder of Mankind Group, is one of the most distinguished business leaders of the country today. He incepted Mankind Pharma in the year 1995 with a mission to serve the society by providing quality life saving drugs at affordable cost.

Under his supervision and expertise, Mankind has flourished from an INR 50 lakhs firm to an INR 1900 crores mammoth in a span of 17 years and is heading towards a turnover of INR 2500 crores.

Mankind is an umbrella for many group companies like DISCOVERY, LIFESTAR, VETKIND, FUTURE and MAGNET, and brands like Unwanted-72, Manforce, Accucheck-Go, Kaloree1, Zenflox, Nuforce, Nurokind etc, and boasts of an R&D centre of its own. It has a strategic tie-up with Roche Diagnostic for the marketing of Accu-Chek Go.

Mr Juneja firmly believes in giving back to the society and hence is devoted to corporate social responsibility. Driven by its commitment towards social welfare & dedicated to the idea of providing family support to orphan children, Mankind has been associated with SOS Children's villages of India to help the underprivileged children live a secured life with natural family environment. It also looks after “Andh Vidyalaya” which educates the blind people with general pattern of the society. Free medicines are distributed to organizations like Navjyoti Foundation (run by Dr. Kiran Bedi) and Helpage India et al whenever there is a requirement.

In his around 40 year – long stint with the pharma industry that commenced in 1974 when he completed his graduation in science and that saw him working with pharma companies like Lupin, Mr Juneja has been accorded with many accolades and awards, the latest jewel being the Business Icon – 2011 (Pharma) Award by Network 18. His passion, determination, strategic thinking, creativity, and confidence continue to motivate the youth of the country.

Mr. B. R. Sikri – Promoter, ABS Mercantiles
Has over 42 years of rich experience in myriad sector including more than 24 years in the field of Pharma sector. This expertise covers Logistics, Supply Chain, Sourcing, Purchasing, marketing and indenting etc.

He is associated with Aurobindo Pharma Ltd., as its Marketing Channel partner for North India as well as a Director in the Joint Venture Company of Aurobindo and B.R. Sikri Associate.

After working for Haryana Government, Central Government, he worked with FACT, a public sector undertaking under the Ministry of Fertilizers and Chemicals. Thereafter, at SOL Pharmaceuticals Ltd as Vice President, he managed the Regulatory affairs, marketing of bulk drugs, Export to CIS Countries and Joint Project in Vietnam.

Mr. B.R. Sikri is also key promoter of following companies:

1. Auronext Pharma Pvt Ltd
2. ABS Mercantiles Pvt Ltd
3. Next Wave ( India)
4.Aumento Pallinos Pvt Ltd
5. White Print- O-Pack
6. BRS Mercantiles Pvt Ltd

He is Chairman of FOPE ( Federation of Pharma Entrepreneurs ) , Vice President , Bulk Drug Manufacturers’ Association (B.D.M.A) ; Secretary, Indian Drug Manufacturers’ Association ( I.D.M.A) (HP & UK) ; Advisor, Himachal Drug Manufacturers’ Association (H.D.M.A) ; President, Pharma Indenting Agents Association (P.I.A.A) .

Mr. R.K Jain – Chairman , East African (India) Overseas
He is a Pharmacist by Training and Education . He has been associated with Indian Pharmaceutical Industry when the indigenous sector was just budding.

He is completing 56 years of his association with the industry. He was associated with leading multinational companies before he stepped into his own country, He has 09 units in Dehradun, (WHO GMP Certified) comprising of all most al sections. He is a founder member of CIPI.

Mr. Umesh Sangi--  Cheif Advisor
The founder member of Confederation of Indian Pharmaceutical Industry. He also plays a vital role in the Pharmaceutical Industry through his leadership in various Pharmaceutical Associations. He is the Ex- Secretary General of Confederation of Indian Pharmaceutical Industry. He has great knowledge of Drugs and Cosmetics Act and other Departments of Excise, Central Excise, State Excise, Labour Department and almost all the Departments of Government which have link to Pharmaceutical Industry. He is known as Think Tank in the field of Pharmaceuticals.

Academics :
B.Pharma in 1968 from Punjab University, Chandigarh

Mr. Vinod Kalani – Director, Oasis Test House Ltd.
Has been managing pharmaceutical companies over last 35 years. He started a commercial analytical laboratory – Oasis Test House Limited , Jaipur in 1981, which is one of the leading testing laboratories in northern india ; and in 1995, he started another commercial analytical laboratory – Oasis Test House at Ahmedabad.

Having graduated in Pharmacy (Hons.) from BITS, Pilani in 1977, he has a rare blend of knowledge and experience – combining first hand knowledge with that of controlling and directing the entire gamut of business activities. His excellent track record is a result of his knack of highly motivated team, dedicated to achieve Company’s objectives.

In 1987, Mr. Vinod Kalani promoted a team of EDP and technical personnel and started – Oasis Infotech which developed a world class Laboratory Information Management System (LIMS) software package – Labmaster / Oasis LIMS ; pioneer in India to bring concept of computerizationof quality assurance activities in pharma industry to a wider front. It is also providing Stability Management System, Change Management System, ERP, SFA etc. software solutions for pharma industry many MNCs and those at USA, UK, Kenya, Ghana, etc.To bridge the gap between industry and academia, Mr. Vinod Kalani has recently established the education and training division.

He is also holding the following important positions :

⇒ President, Rajasthan Pharmaceutical Manufacturers Association;
⇒ Vice Chairman, Confederation of Indian Pharma Industry (CIPI);
⇒ Gen Sec, Federation of Pharma Entrepreneurs (FOPE) ;
⇒ Recipient of IPA Fellowship Award 2008;
⇒ Chairman, MSME Sub-Committee, Indian Pharmaceutical Manufacturers’ Association (IDMA);
⇒ CEC Member, Indian Pharmaceutical Association (IPA), Mumbai.

Mr. Jatish Seth - Director, Srushti Pharmaceuticals Pvt. Ltd.

From 1987 onwards implemented the project of setting up of M/s. Srushti Pharmaceuticals Pvt. Ltd. As one of the founder directors and till date managing the organization/business and all its activities on day to day basis.

• Born in Addis Ababa, Ethiopia and had his early education in Addis Ababa.

• Bachelor in Pharmacy from College of Pharmacy, Manipal now Manipal University

• Started his career with MITL which got merged with Astra Zeneca Limited.

• Managed family chemicals and related business involving international trade with countries like Japan, South Korea, Yemen, India etc. in Addis Ababa Ethiopia.

• Joined Smithkline Beecham Pharmaceuticals, currently part of GlaxoSmithkline GSK, as in-charge of production of Pharmaceutical products.

• Established Srushti Pharmaceuticals Bangalore, in the year 1990, and has been the promoter director since inception.

• Srushti Pharmaceuticals specializes in new drug delivery systems, and has extended the technology to other sectors including Space and Defense Sectors. Holds number of patents.

• Has been very actively associated with KDPMA- Karnataka Drugs and Pharmaceuticals Manufacturers’ Association since more than twenty five years, and has the credit of holding posts of Joint secretary Secretary and President,

• Currently Vice Chairman of Steering Committee member of Karnataka Drugs and Pharmaceuticals Manufacturers Association – KDPMA

• Executive Member of the CII national committee of Pharmaceuticals .

• Chairman National Alliance of Pharmaceutical Manufacturers’ Association

• Secretary FOPE

• Secretary General of Confederation of Indian Pharmaceutical Industry

  Served as :-

• Member of the Regional Advisory Committee, Central Excise & Service Tax, Government of India

• Member of the Export Facilitation Committee, Government of Karnataka

• Invited as a delegate to pharmaceutical trade and technology forums in South Korea, Ethiopia and China

Mr. Ashok Windlass - Managing Director, Windlass Pvt. Ltd.
Has been a quintessential entrepreneur since last 42 years and has been responsible for the growth of Windlass family in various verticals. He has been intimately involved in the foray of the group in pharmaceuticals sector and provided leadership to Windlas Biotech Limited since last its formation in 2001. He is the Managing Director of Windlass Biotech Limited and it has been his drive and dedication which has lead to the conceptualization and erection of the Windlass Healthcare Pvt. Ltd. a subsidiary company of Windlass Biotech Limited and he remains actively involved in important strategic decisions of the all the group companies.

He also plays a vital role in the pharmaceutical industry through his leadership role in various pharmaceutical associations of the sate and the nation. He is the Vice President of Federation of Pharmaceutical Entrepreneurs (FOPE) and the President of Uttarakhand Pharmaceutical Alliance, Co- Chairman of Expert Committee (SME) of Indian Chamber of Commerce and Industries. He is also a founding member of Confederation of Indian Industries (CII) for the Dehradun Chapter

Dr. L. Ramanathan-General Manager-Regulatory Affairs and BD
Apex Laboratories Private Limited, Chennai, Tamil Nadu.
He has passed Master of Pharmacy from JSS college of Pharmacy Ooty with Distinction in 2006 and later did PhD from Madurai Kamaraj University (Split site with Technion-Israel Institute of Technology, Israel) in 2011.

He has been awarded with Israel Government scholarship 2008-2009, worked in Nanofoods project (European seventh frame work project) on developing Nano complexes for delivering bio active agents, UGC-JRF and UGC-SRF (Meritorious Students).

Founded in 1978, Apex Laboratories Private Limited is a family owned company engaged in manufacturing finished dosage formulations; currently rated among the top 50 pharma company in India with Flagship brand Zincovit. Global sales network spanning over 28 countries, including Europe, Asia, Africa, South America and the Far East, with over 2,200 channel partners across India with four state of the art manufacturing plants (topical, solid oral dosage form, liquids and herbals) accredited by EU-GMP, WHO-GMP, ISO:9001:2015 and UK-MHRA. Apex has a Department of Scientific & Industrial Research (DSIR) approved R&D centre where it has developed and applied for nearly 117 patents.

He holds U.S. Patent with Application No.: 63/597,279 Entitled: METHODS FOR TREATING SKIN DISORDERS Filed: 8/11/2023; and 3 international patents in pipeline.He has 8 International Publications & 1 National Publication.

His professional experience includes Research and Development, Clinical Trials, Pharmacovigilance, Business Development, Regulated market Filings for US-FDA & EU & Innovative Products and attended Pre IND meeting with USFDA at Maryland, USA and Scientific Advice meeting with BfArM, at Germany.

His research interest includes Dermatology, flow chemistry, liposomal delivery, nanotechnology, Retrosynthetic methods for developing new chemical entity, Nutraceuticals and repurposing.

His current positions in various Pharma Associations includes Vice President:- TN PMA (Tamil Nadu Pharmaceutical Manufacturers Association), Joint Secretary:- (Confederation of Indian Pharmaceutical Industry) CIPI, Executive Committee Board Member & Nutra Committee :- FOPE (Federation of Pharma Entrepreneurs), Treasurer :- FOSIPMA, Member of IPA, IDMA, HADSA, &TASUDMA and Editor of Pharmat Journal by TN PMA.

Presently, he is a Resource Person of College of Pharmacy, JSS University, Ooty, Expert Member for the Board of Studies for College of Pharmacy, SRM University, Kattankulathur, Expert Member for the Board of Studies, College of Pharmacy, SRMC University, Porur.

Mr. Sudesh Kumar
A science graduate from Agra University having a versatile experience of working in pharmaceuticals sector. Last employment held was of a commercial manager in a reputed pharmaceutical company where in addition to other responsibility was required by the management to coordinate between production and other departments for maximizing the production. Some of his suggestions for streamlining the procedures were accepted by the management and were appreciated by the chairman.